CA Patent

CA2492747A1 — Medicaments containing vardenafil hydrochloride trihydrate

Assigned to Bayer Intellectual Property GmbH · Expires 2004-01-22 · 22y expired

What this patent protects

The invention relates to a method for producing medicaments that contain vardenafil hydrochloride, essentially as trihydrate in solid form, and to medicaments that can be obtained according to this method.

USPTO Abstract

The invention relates to a method for producing medicaments that contain vardenafil hydrochloride, essentially as trihydrate in solid form, and to medicaments that can be obtained according to this method.

Drugs covered by this patent

Patent Metadata

Patent number
CA2492747A1
Jurisdiction
CA
Classification
—
Expires
2004-01-22
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Intellectual Property GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.